3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
5
Phase 2/3
1
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
6
Endometrial Neoplasms
4
Progesterone Resistance
2
Polycystic Ovary Syndrome
2
Endometrial Hyperplasia
2
Uterine Neoplasms
1
Obesity
1
Neoplasm Metastasis
1
Inflammatory Breast Neoplasms
1
Infertility
1
Hydatidiform Mole
1
Hormone Receptor Positive HER-2 Negative Breast Cancer
1
Gestational Trophoblastic Disease
1
Cystadenocarcinoma, Serous
1
Carcinoma, Ductal, Breast
1
Breast Diseases
1
Interventions
Paclitaxel
2
Letrozole
1
Lapatinib
1
Gonadotropin-Releasing Hormone
1
Doxorubicin
1
Cisplatin
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Carcinoma, Ductal, Breast
×
Letrozole
×
Clear all
NCT02221999
2023-08-29
SHPD002
RenJi Hospital
Phase 2/3
Active not recruiting
250 enrolled